Work

Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease

Year: 1995

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/j.1365-2036.1995.tb00438.x

Authors: A. B. R. THOMSON, J. P. WRIGHT, M. VATN, R. J. BAILEY, D. RACHMILEWITZ, M. ADLER, K. A. WILSON‐LYNCH, on behalf of The International Mesasal Maintenance Study Group

Institution: University of Alberta

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2056425879

FWCI: 0.796

Cites: 27

Cited by: 53

Related to: 10